Skip to main content

Table 1 Clinical characteristics of subjects in this study

From: Identification of serum β-catenin as a biomarker in patients with HBV-related liver diseases

Parameter

HC

HHC

CHB

HBLC

HCC

Number of subjects

78

41

77

63

61

Gender (male, %)

45 (57.6%)

29 (70.7%)

50 (64.9%)

47 (74.6%)

39 (63.9%)

Age (range, mean)

19–67, 42.1

17–59, 39

26–66, 45.3

32–68, 48.2

37–67, 53.5

ALT (U/L)

15.8 ± 7.43

16.3 ± 8.33

143.8 ± 144.1

46.11 ± 41.37

16.46 ± 6.56

AST (U/L)

17.98 ± 6.32

17.34 ± 7.91

173.1 ± 254.5

61.52 ± 79.3

21.5 ± 7.25

HBV DNA (log10 IU/mL)

N/A

2.58 ± 0.69

5 ± 1.65

4.96 ± 1.7

4.97 ± 2.04

  1. For age, ALT, AST, HBV DNA titres, data are presented as mean ± SD
  2. N/A not available